During the recent session, PainReform Ltd (NASDAQ:PRFX)’s traded shares were 2.46 million, with the beta value of the company hitting 0.56. At the last check today, the stock’s price was $1.3, reflecting an intraday loss of -5.81% or -$0.08. The 52-week high for the PRFX share is $16.63, that puts it down -1179.23 from that peak though still a striking 3.85% gain since the share price plummeted to a 52-week low of $1.25. The company’s market capitalization is $2.62M, and the average intraday trading volume over the past 10 days was 0.32 million shares, and the average trade volume was 1.42 million shares over the past three months.

PainReform Ltd (NASDAQ:PRFX) trade information

PainReform Ltd (PRFX) registered a -5.81% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -5.81% in intraday trading to $1.3, hitting a weekly high. The stock’s 5-day price performance is -7.16%, and it has moved by -34.02% in 30 days. Based on these gigs, the overall price performance for the year is -61.26%. The short interest in PainReform Ltd (NASDAQ:PRFX) is 93736.0 shares and it means that shorts have 2.11 day(s) to cover.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 12.33%.

PRFX Dividends

PainReform Ltd is due to release its next quarterly earnings on 2024-Aug-15. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

PainReform Ltd (NASDAQ:PRFX)’s Major holders

PainReform Ltd insiders own 9.62% of total outstanding shares while institutional holders control 2.17%, with the float percentage being 2.40%.

Data provided on Sep 30, 2024 indicates that Fidelity NASDAQ Composite Index Fund owns about 80.0 shares. This amounts to just over 0.01 percent of the company’s overall shares, with a $104.0 market value.